Health
New immunotherapy shows promise against rare childhood cancer – EurekAlert
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results in children with neuroblastoma,…
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results in children with neuroblastoma, a rare form of childhood cancer.
For this proof-of-principle study, researchers at the UCL Great Ormond Street Institute for Child Health (GOS ICH) and the UCL Cancer Institute modified the patient’s own T-cells (a type of immune cell), equipping them to recognise and kill neuroblastoma tumour cells.
Twelve children with relapsed…
-
Business18 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News23 hours agoBrisbane council budget 2025: Winners and losers
-
Noosa News18 hours agoBrisbane’s 2025–26 budget revealed: rate hikes, service fee rises and major infrastructure plans
-
Noosa News24 hours agoPolice officer found not guilty of using restricted database to track former partner